References
- Balderrabano-Saucedo NA, Sanchez-Urbina R, Sierra-Ramirez JA, et al. (2013). Polymorphism 677C –> T MTHFR gene in Mexican mothers of children with complex congenital heart disease. Pediatr Cardiol 34:46–51
- Brandalize AP, Bandinelli E, dos Santos PA, et al. (2009). Evaluation of C677T and A1298C polymorphisms of the MTHFR gene as maternal risk factors for Down syndrome and congenital heart defects. Am J Med Genet A 149A:2080–7
- Chambers JC, Ireland H, Thompson E, et al. (2000). Methylenetetrahydrofolate reductase 677 C–>T mutation and coronary heart disease risk in UK Indian Asians. Arterioscler Thromb Vasc Biol 20:2448–52
- Garcia-Fragoso L, Garcia-Garcia I, Leavitt G, et al. (2010). MTHFR polymorphisms in Puerto Rican children with isolated congenital heart disease and their mothers. Int J Genet Mol Biol 2:43–7
- Gong D, Gu H, Zhang Y, et al. (2012). Methylenetetrahydrofolate reductase C677T and reduced folate carrier 80 G > A polymorphisms are associated with an increased risk of conotruncal heart defects. Clin Chem Lab Med 50:1455–61
- Hobbs CA, James SJ, Jernigan S, et al. (2006). Congenital heart defects, maternal homocysteine, smoking, and the 677 C > T polymorphism in the methylenetetrahydrofolate reductase gene: evaluating gene-environment interactions. Am J Obstet Gynecol 194:218–24
- Hoffman JI, Kaplan S. (2002). The incidence of congenital heart disease. J Am Coll Cardiol 39:1890–900
- Junker R, Kotthoff S, Vielhaber H, et al. (2001). Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease. Cardiovasc Res 51:251–4
- Klerk M, Verhoef P, Clarke R, et al. (2002). MTHFR 677C–>T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 288:2023–31
- Lee CN, Su YN, Cheng WF, et al. (2005). Association of the C677T methylenetetrahydrofolate reductase mutation with congenital heart diseases. Acta Obstet Gynecol Scand 84:1134–40
- Mamasoula C, Prentice RR, Pierscionek T, et al. (2013). Association between C677T polymorphism of methylene tetrahydrofolate reductase and congenital heart disease: meta-analysis of 7697 cases and 13 125 controls. Circ Cardiovasc Genet 6:347–53
- Marelli AJ, Mackie AS, Ionescu-Ittu R, et al. (2007). Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 115:163–72
- Mehlig K, Leander K, de Faire U, et al. (2013). The association between plasma homocysteine and coronary heart disease is modified by the MTHFR 677C > T polymorphism. Heart 99:1761–5
- Nie Y, Gu H, Gong J, et al. (2011). Methylenetetrahydrofolate reductase C677T polymorphism and congenital heart disease: a meta-analysis. Clin Chem Lab Med 49:2101–8
- Pereira AC, Xavier-Neto J, Mesquita SM, et al. (2005). Lack of evidence of association between MTHFR C677T polymorphism and congenital heart disease in a TDT study design. Int J Cardiol 105:15–18
- Sanchez-Urbina R, Galaviz-Hernandez C, Sierra-Ramirez JA, et al. (2012). Methylenetetrahydrofolate reductase gene 677CT polymorphism and isolated congenital heart disease in a Mexican population. Rev Esp Cardiol (Engl Ed) 65:158–63
- van Beynum IM, den Heijer M, Blom HJ, Kapusta L. (2007). The MTHFR 677C->T polymorphism and the risk of congenital heart defects: a literature review and meta-analysis. QJM 100:743–53
- Wang B, Liu M, Yan W, et al. (2013). Association of SNPs in genes involved in folate metabolism with the risk of congenital heart disease. J Matern Fetal Neonatal Med 26:1768–77
- Yin M, Dong L, Zheng J, et al. (2012). Meta analysis of the association between MTHFR C677T polymorphism and the risk of congenital heart defects. Ann Hum Genet 76:9–16
- Zhu WL, Li Y, Yan L, et al. (2006). Maternal and offspring MTHFR gene C677T polymorphism as predictors of congenital atrial septal defect and patent ductus arteriosus. Mol Hum Reprod 12:51–4
- Zidan HE, Rezk NA, Mohammed D. (2013). MTHFR C677T and A1298C gene polymorphisms and their relation to homocysteine level in Egyptian children with congenital heart diseases. Gene 529:119–24